THE GAME CHANGER

Retatrutide

Grade C — Moderate

The most powerful weight loss solution available—24% average weight loss in trials.

Also known as: LY3437943; GGG Tri-Agonist

Weight Management
Appetite & Metabolic Control
Hormonal Regulation
Anti-Aging & Longevity

Overview

Retatrutide is the most powerful weight loss peptide yet developed - a tri-agonist that activates GLP-1, GIP, AND glucagon receptors simultaneously. In trials, it produced 24% weight loss in 48 weeks, significantly outperforming single-agonist drugs. It suppresses appetite, improves insulin sensitivity, and increases your body's calorie burning through thermogenesis.

Key Benefits & Mechanisms

Appetite Suppression

GLP-1 activation suppresses appetite and improves insulin secretion

GIP Activation

Boosts insulin and improves lipid metabolism

Glucagon Activation

Increases energy expenditure and fat oxidation

Liver Fat Reduction

Promotes hepatic fat oxidation and NAFLD reversal

Dosing Guide

Dosage

Start at 0.5 mg weekly, titrate to 2.5-5 mg weekly

Schedule

weekly

Cycle

12 weeks on, 12 weeks off (per clinical trials)

Pro Tip

Slow titration is key - increase dose every 4 weeks to minimize GI effects

This peptide requires titration — start with a lower dose and increase gradually.

Safety Profile

C

Moderate Safety

Moderate

Still in clinical trials. GI side effects are common but manageable.

Investigational drug - not yet approved. Titrate slowly to minimize side effects.

Possible Side Effects

Nausea
Vomiting
Diarrhea
Injection site irritation

What to Expect

Week 1-4

Reduced appetite, possible GI adjustment period

Week 4-12

Significant weight loss (10-15%)

Week 12-24

Continued weight loss, metabolic improvements

Week 24-48

Peak weight loss (~24% in trials)

Weight loss typically begins within the first 2 weeks.

Who Is This For

Those with significant weight to lose
People who haven't responded to other GLP-1 drugs
Those with type 2 diabetes and obesity
Anyone seeking cutting-edge metabolic therapy
People interested in fatty liver reversal

Research References

[1]Jastreboff et al. 2023 - Retatrutide Phase 2 Trial

Related Peptides

CJC-1295 (no DAC)

B

THE GH SUSTAINER

Long-acting growth hormone releaser for muscle, recovery and anti-aging

BAM-15

B

THE CALORIE BURNER

Make your cells burn more fuel - mitochondrial uncoupling for fat loss

Cardiogen

A

THE CARDIAC REGENERATOR

Four-amino-acid peptide for heart repair and regeneration

Chitomur

A

THE BLADDER HEALER

Restore bladder function and urinary comfort

Glandokort

A

THE ADRENAL REJUVENATOR

Restore adrenal function and stress resilience

Gotratix

A

THE MUSCLE REGENERATOR

Muscle peptide for strength, endurance, and recovery

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App